Forrest Innovations

EQUITY

Company overview

A biological solution for mosquito vectored disease such as Zika, Yellow Fever, Malaria and Dengue.

Maturity

Sales, or licensing phases

Sector

Biotechnology

Market

Mosquito-borne diseases

Goal

£780,000.00

You can indicate your investment interest in this opportunity without any commitment.

Tackling the deadliest animal in the world

Perhaps surprisingly, at the top of the list of human-killing animals sits a rather humble animal: the mosquito, accountable for almost a million deaths every year. Malaria, Dengue Fever, Zika and a horde of other infections and parasites are transmitted by the mosquito and cause hundreds of millions of people to suffer terribly.

A cure for malaria or Dengue may hopefully be developed, but tackling these diseases has long-since been a matter of tackling the mosquito population. Less mosquitoes, less disease – simple math. Admittedly, the biology is much more complicated.

Reducing the mosquito population is one of the Holy Grails of global health and has been attempted using an amazingly inventive array of solutions, from fish to lasers and from pesticides to genetic engineering. Everyone seems to hate these insects and to have an inspired desire to exterminate them – some prominent biologists have even publicly called for the complete extinction of the Anopheles and Aedes species of mosquitoes. That does result into a very hungry market for mosquito-killers.

“The more sterile male mosquitoes are released, the quicker the population is reduced. “

  • Click to keep reading (2 min more)

    A solution that does not mean spraying vast stretches of nature with deadly pesticides is the release of sterile male mosquitoes into the wild. These male mosquitoes (and remember, male mosquitoes don’t bite) would mate normally with females, leaving them with no offspring. The more sterile male mosquitoes are released, the quicker the population is reduced. With more male mosquitos in the environment, these compete to mate with the female mosquitoes, resulting in a lower impregnation rate overall. But killing mosquitoes has always been preferred to sterilising them: it’s just a lot easier – just try both and see for yourself.

    The traditional method of sterilizing males has always been radiation, which is indeed very effective… but tends to leave the poor mosquitoes in bad shape, making them unable to mate.

    New RNA based techniques (RNA is a code-carrying molecule similar to DNA), like those developed by Israeli company Forrest Innovations, have proven effective at creating sterile male mosquitoes that are also fit enough to mate: mosquito eggs are collected from the environment, hatched, multiplied, and then treated to render the adult males sterile. These are then released into the wild by the millions.

    This has already been field-tested with promising results, culminating in a contract for full-scale implementation in Brazil. The results of this first project could open the door to a multi-billion global market and major advances in the fight against mosquito-borne diseases.

Daniel Oliver

Capital Cell CEO, Biologist and Crowdfunding Expert.
See my LinkedIn
daniel-project

How the company differentiates themselves

HIGHLIGHTS

  • Natural solution, fast-flexible deployment and massive aerial release capabilities
  • Current founder and CEO was cofounder and CTO of Beeologics, sold to Monsanto in 2011 for $125M on a total of under $7M total investment
  • Sterile insect technology and strategy to reduce mosquito-borne disease
  • The treatment is applied to larvae, and results in no progeny in subsequent generations
  • The solution is based on years of know-how and practical application of the founders of Forrest Innovations

What our experts say  

THIS PROJECT HAS BEEN REVIEWED BY THE BIOEXPERT NETWORK OF 500+ PHD LEVEL SCIENTISTS, PHYSICIANS, IP LAWYERS, CONSULTANTS AND INVESTMENT PROFESSIONALS. THEY HAVE RATED THIS PROJECT BASED ON VARIOUS PARAMETERS, INCLUDING: THE SCIENTIFIC VALIDITY, TEAM EXPERTISE, ROUTE TO MARKET, VALUATION AND INVESTABILITY.

The final ratings  

THESE ARE THE AVERAGE SCORES, TAKEN FROM A VARIETY OF REVIEWS PERFORMED BY THE BIOEXPERT NETWORK AND OUR INTERNAL ANALYTICAL TEAM.

Team

WHAT'S THIS?
THE PROFESSIONAL EXPERTISE OF THE TEAM AND OVERALL STRUCTURE OF THE COMPANY.

Science

WHAT'S THIS?
THE CREDIBILITY OF THE SCIENTIFIC RESEARCH AND DEVELOPMENT, THE STATUS OF THE PATENT AND THE ACCURACY OF THE INFORMATION PRESENTED.

Innovation

WHAT'S THIS?
THE NOVEL MERIT OF THE PROJECT AND COMPARISON OF THE COMPANY TO COMPETITORS.

Business

WHAT'S THIS?
THE MATURITY OF THE COMPANY, AND APPROPRIACY OF THE BUSINESS MODEL, PLAN AND ROUTE TO MARKET.

Finances

WHAT'S THIS?
THE PRESENTATION OF FINANCIAL INFORMATION, INCLUDING PRE-MONEY VALUATION, BALANCE SHEET, FORECAST, EXPECTED ROI, EXIT AND ROI JUSTIFICATION.

Approved by the Bioexpert Network

The BioExpert Network is an independent and exclusive network of industry experts in the sectors of life science and investment. Only proposals which receive the most positive responses, in terms of novel concepts, scientific validity and financial accuracy successfully progress to funding campaign stage on the Capital Cell online platform.

Company Information

Who we are

 

TEAM

Purpose of the project

 

FROM PROBLEM TO SOLUTION

THE PROBLEM

Mosquitoes are the deadliest creatures on the planet. Mosquito-borne diseases such as ZIKA, Dengue, Yellow fever, Malaria and Chikungunya plague half the world’s population with severe annual consequences to human health and an enormous economic burden.

THE SOLUTION

Forrest is implementing its Natural Vector Control (NVC) solution to control mosquitoes. Harnessing a naturally occurring mechanism (RNAi) Forrest produce 100% sterile Non-GM male mosquitoes that are released en-masse from airplanes to compete with the wild male population and subsequently reduce the ambient population. Forrest’s key operational process combines Modular Mobile Mosquito Units (MMMU) for mass production of NVCs and massive aerial release capabilities for deployment of efficient mosquito control.

Contact the Company

CONTACT THE COMPANY

Leave a Reply